New eczema drug TRB-061 enters first human safety trials

NCT ID NCT06934252

First seen Mar 07, 2026 · Last updated May 16, 2026 · Updated 8 times

Summary

This study tests an experimental drug called TRB-061 in healthy adults and people with moderate-to-severe atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body handles it. Participants receive either the drug or a placebo as injections under the skin, with healthy volunteers getting up to 3 doses and eczema patients getting up to 4 doses over several weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CMAX Clinical Research Pty Ltd

    RECRUITING

    Adelaide, South Australia, 5000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cornerstone Centre for Clinical Research

    NOT_YET_RECRUITING

    Coorparoo, Queensland, 4151, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medical Research Institute of New Zealand

    NOT_YET_RECRUITING

    Newtown, Wellington Region, 6021, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Clinical Research Dunedin

    NOT_YET_RECRUITING

    Dunedin, Otago, 9016, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Clinical Research Kapiti

    NOT_YET_RECRUITING

    Waikanae, Wellington Region, 5036, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Clinical Research Pukekohe

    NOT_YET_RECRUITING

    Pukekohe, Auckland, 2120, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Pacific Clinical Research Network-Tasman

    NOT_YET_RECRUITING

    Nelson, Tasman District, 7011, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Pacific Clinical Research Network-Wellington

    NOT_YET_RECRUITING

    Upper Hutt, Wellington Region, 5018, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Pacific Clinical Research Network-West Auckland

    NOT_YET_RECRUITING

    Auckland, 0600, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical Brisbane Pty Ltd

    NOT_YET_RECRUITING

    Albion, Brisbane, 4010, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical Research - Canberra Trial Clinic

    NOT_YET_RECRUITING

    Belconnen, Australian Capital Territory, 2617, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical Research Central Coast

    NOT_YET_RECRUITING

    Kanwal, New South Wales, 2259, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical Research Melbourne

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3070, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical Research Western Sydney

    NOT_YET_RECRUITING

    Blacktown, New South Wales, 2148, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.